Expression of Concern: Combined VLA-4–Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma

The editors have been informed by the corresponding author and the University of Pittsburgh that an institutional research misconduct investigation determined that data presented in Figure 5B were falsified by the first author in the reported article ([1][1]). According to information provided to